JP2022542803A5 - - Google Patents
Info
- Publication number
- JP2022542803A5 JP2022542803A5 JP2022502217A JP2022502217A JP2022542803A5 JP 2022542803 A5 JP2022542803 A5 JP 2022542803A5 JP 2022502217 A JP2022502217 A JP 2022502217A JP 2022502217 A JP2022502217 A JP 2022502217A JP 2022542803 A5 JP2022542803 A5 JP 2022542803A5
- Authority
- JP
- Japan
- Prior art keywords
- polymorph
- substantially shown
- xrpd pattern
- graph
- dsc
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962875355P | 2019-07-17 | 2019-07-17 | |
| US62/875,355 | 2019-07-17 | ||
| PCT/US2020/042390 WO2021011809A1 (en) | 2019-07-17 | 2020-07-16 | Polymorphs of (r)-n-(5-(5-isopropyl-1,2,4-oxadiazol-3-yl)-2,3-dihydro-1h-inden-1-yl)-2-methyl-2h-tetrazole-5-carboxamide |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022542803A JP2022542803A (ja) | 2022-10-07 |
| JP2022542803A5 true JP2022542803A5 (https=) | 2023-07-25 |
Family
ID=71995105
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022502217A Pending JP2022542803A (ja) | 2019-07-17 | 2020-07-16 | （ｒ）－ｎ－（５－（５－イソプロピル－１，２，４－オキサジアゾール－３－イル）－２，３－ジヒドロ－１ｈ－インデン－１－イル）－２－メチル－２ｈ－テトラゾール－５－カルボキサミドの多形 |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US20220274969A1 (https=) |
| EP (1) | EP3999181B1 (https=) |
| JP (1) | JP2022542803A (https=) |
| KR (1) | KR20220082803A (https=) |
| CN (1) | CN114667283B (https=) |
| AU (1) | AU2020315433A1 (https=) |
| BR (1) | BR112022000523A2 (https=) |
| CA (1) | CA3144974A1 (https=) |
| CL (1) | CL2022000089A1 (https=) |
| ES (1) | ES2982707T3 (https=) |
| IL (1) | IL289881A (https=) |
| MX (1) | MX2022000498A (https=) |
| NZ (1) | NZ784931A (https=) |
| PH (1) | PH12022550084A1 (https=) |
| TW (1) | TW202116764A (https=) |
| WO (1) | WO2021011809A1 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2019144041A1 (en) | 2018-01-19 | 2019-07-25 | Cytokinetics, Inc. | Dihydrobenzofuran and inden analogs as cardiac sarcomere inhibitors |
| JP7610985B2 (ja) | 2018-06-26 | 2025-01-09 | サイトキネティックス， インコーポレイテッド | 心臓サルコメア阻害剤 |
| JP7438148B2 (ja) | 2018-06-26 | 2024-02-26 | サイトキネティックス， インコーポレイテッド | 心臓サルコメア阻害剤 |
| WO2024179422A1 (zh) * | 2023-03-02 | 2024-09-06 | 苏州科睿思制药有限公司 | Aficamten的共晶及其制备方法和用途 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE552236T1 (de) * | 2003-01-14 | 2012-04-15 | Cytokinetics Inc | Verbindungen, zusammensetzungen und verfahren zur behandlung von herzinsuffizienz |
| WO2007078815A2 (en) * | 2005-12-16 | 2007-07-12 | Cytokinetics, Inc. | Certain chemical entities, compositions, and methods |
| WO2019144041A1 (en) * | 2018-01-19 | 2019-07-25 | Cytokinetics, Inc. | Dihydrobenzofuran and inden analogs as cardiac sarcomere inhibitors |
-
2020
- 2020-07-16 BR BR112022000523A patent/BR112022000523A2/pt unknown
- 2020-07-16 PH PH1/2022/550084A patent/PH12022550084A1/en unknown
- 2020-07-16 NZ NZ784931A patent/NZ784931A/en unknown
- 2020-07-16 MX MX2022000498A patent/MX2022000498A/es unknown
- 2020-07-16 JP JP2022502217A patent/JP2022542803A/ja active Pending
- 2020-07-16 CA CA3144974A patent/CA3144974A1/en active Pending
- 2020-07-16 ES ES20753564T patent/ES2982707T3/es active Active
- 2020-07-16 TW TW109124109A patent/TW202116764A/zh unknown
- 2020-07-16 WO PCT/US2020/042390 patent/WO2021011809A1/en not_active Ceased
- 2020-07-16 AU AU2020315433A patent/AU2020315433A1/en not_active Abandoned
- 2020-07-16 EP EP20753564.2A patent/EP3999181B1/en active Active
- 2020-07-16 US US17/627,590 patent/US20220274969A1/en active Pending
- 2020-07-16 KR KR1020227002979A patent/KR20220082803A/ko not_active Ceased
- 2020-07-16 CN CN202080059957.7A patent/CN114667283B/zh active Active
-
2022
- 2022-01-12 CL CL2022000089A patent/CL2022000089A1/es unknown
- 2022-01-16 IL IL289881A patent/IL289881A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022540668A5 (https=) | ||
| JP2022542803A5 (https=) | ||
| JP2021511331A5 (https=) | ||
| JP4422477B2 (ja) | ヘテロアリールスルホニル側鎖を有するアントラニル酸アミド、その製造方法、その医薬または診断助剤としての使用、およびこの化合物を含有する医薬製剤 | |
| CN110357789B (zh) | 作为dhodh抑制剂的n-取代丙烯酰胺衍生物及其制备和用途 | |
| JP2021535164A5 (https=) | ||
| JP2024508526A5 (https=) | ||
| TW200300760A (en) | 5-Sulphanyl-4H-1,2,4-triazole derivatives and their use as a medicament | |
| JP2021529185A5 (https=) | ||
| TW202021952A (zh) | 製備ｐｄｅ４抑制劑之方法 | |
| TW201031645A (en) | Thiadiazole and oxadiazole derivatives, preparation thereof and therapeutic use thereof | |
| HUP0203444A2 (hu) | (S)-2-Etoxi-3-[4-{2-[4-(metánszulfonil-oxi)-fenil]-etoxi}-fenil]-propionsav kristályos formája, eljárás az előállítására, ezt tartalmazó gyógyszerkészítmény és alkalmazása | |
| JP2019523273A (ja) | ベリノスタットの多形形態、およびその調製のためのプロセス | |
| WO2006022374A1 (ja) | ２－フェニルピリジン誘導体 | |
| WO2013144903A1 (en) | Processes for the preparation of dabigatran etexilate | |
| JP2011527330A (ja) | スニチニブリンゴ酸塩の結晶形の調製方法 | |
| EP2707364A1 (en) | Process for the manufacture of dabigatran etexilate and intermediates thereof | |
| US20010031878A1 (en) | Novel processes for making- and a new crystalline form of- leflunomide | |
| JP2022540678A5 (https=) | ||
| JP2024546844A5 (https=) | ||
| WO2004000813A1 (ja) | フェノキシピリジン誘導体又はその塩 | |
| JP2013540780A (ja) | イミダゾール誘導体並びにその製造法及び使用 | |
| US11339145B2 (en) | Synthesis of cerdulatinib | |
| CN111592500A (zh) | ARB-NEPi复合物、晶型、制备方法及应用 | |
| CN103068392A (zh) | 苯甲酸阿格列汀的多晶形物 |